Welcome to NovaFlux where we are known to create disruptive technologies and develop medical devices to solve some of the most complex problems in the healthcare industry today. We strive to separate ourselves from the rest of the industry by developing products that protected by landmark IP. Our devices and solutions add new dimensions to the fields of hemodialysis, endoscopy, and infection control.
NovaFlux is a Princeton-based medical technology company incorporated in the State of New Jersey specializing in the development disruptive medical devices. NovaFlux started the development of its famous Two-Phase Flow (TPF) technology platform, and has expanded its IP protection in the United States and worldwide. Our Two-Phase Flow technology is based on creating a high-velocity turbulent flow mixture of a gas and a liquid to clean narrow tubes and lumens about 1000 times better than the conventional liquid flushing currently practiced in the healthcare industry. We are able to clean the internal surfaces of capillaries with dimensions of 200 microns up to 20 cm diameter pipes to levels that cannot be matched by any other technology.
Our IP-protected TPF technology cleans narrow lumens by the impact forces of high-velocity droplets from a gas stream and by the shear forces generated as liquid slides over the lumen surfaces at the three-phase contact line. The air velocity used in the TPF technology can reach up to 160 kilometers/hour. Despite the generation of high-shear forces, the TPF technology is safe to clean delicate medical devices without degrading them. Our technology covers applications in hemodialysis, endoscopy, dialysis water systems and membranes.
NovaFlux is focusing on developing nano-structured complex fluids to clean luminal medical devices including endoscopes and equipment in life sciences.
NovaFlux scientists and engineers have exceptional expertise and capability in developing high-value medical equipment and devices that are currently used to treat patients in healthcare facilities.
NovaFlux is highly regarded in medical technology innovations and has received funding in excess of $30 million from the National Institutes of Health, making it a major NIH funding recipient in New Jersey over the past few years.
NovaFlux has been successful in licensing its technologies to major multi-billion dollar companies.
To find out more about NovaFlux, please visit our Contact page.
NovaFlux management is comprised of top level professionals with multidisciplinary education and experience. With the combined expertise of key individuals and advisors, NovaFlux has demonstrated exceptional capability in developing and producing disruptive technology in several fields. We are proud to announce many impressive collaborations with top talent from around the globe.
Discovery of Novel Medical Technologies
Medical Device Design/Engineering
Device Simulation, Testing and Evaluation
Cleaning and Disinfection Formulation Development
Analytical Methods/Protocol Development
Fluid Dynamics and High-speed Photography